Aug 8, 2022 Press Releases
PDF Version SAN FRANCISCO, Calif. – August 8, 2022 – Attralus, Inc., a clinical stage biopharmaceutical company developing transformative medicines to improve the lives of patients with systemic amyloidosis, announced today that the U.S. Food and Drug...
Jun 14, 2022 Press Releases
PDF Version AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosis AT-01 visualizes and quantifies organ-specific changes in amyloid load over time AT-01 detected patients with diverse types of systemic amyloidosis, by...
Jun 14, 2022 Posters & Publications
PDF Version Source Author: Jonathan S. Wall, Emily B. Martin, Alan Stuckey, Dustin Powell, R. Eric Heidel, Ronald Lands, Stephen J. Kennel AUTHORS: Jonathan S. Wall, Emily B. Martin, Alan Stuckey, Dustin Powell, R. Eric Heidel, Ronald Lands, Stephen J. Kennel...
Jun 14, 2022 Posters & Publications
PDF Version Source Author: Emily B. Martin, Alan Stuckey, R. Eric Heidel Stephen J. Kennel Amy J. Weisman and Jonathan S. Wall AUTHORS: Emily B. Martin, Alan Stuckey, R. Eric Heidel Stephen J. Kennel Amy J. Weisman and Jonathan S. Wall CLICK HERE TO VIEW...
